Siemens Claims Top IVD Slot With $7 Billion Dade Behring Purchase
This article was originally published in The Gray Sheet
Siemens' medical unit solidified its status July 25 as the only company offering a comprehensive suite of both imaging and in vitro diagnostic products with its $7 billion acquisition of Dade Behring
You may also be interested in...
The firm's health-care division bought private next-generation sequencing firm NEO New Oncology for an undisclosed amount.
Device firms have already been active with M&A deals in 2014. Here are 10 companies to look for as potential acquisition targets going forward.
Siemens has established itself as a leader in both imaging and in vitro diagnostics with the aid of recent multibillion-dollar acquisitions, but the company's ability to leverage its IT expertise will be critical to tie the pieces together, the firm says